Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary endpoint was the success rate of adjuvant isonicotinic acid hydrazide (INH) and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy.
According to the American college of obstetricians and gynecologists (2005), medical abortion is an acceptable alternative for surgical procedures in pregnant women with gestational age of less than 10 weeks based on the last menstrual period
Oral or vaginal misoprostol causes complete abortion in almost 85% of cases within seven days before the 12th week
Adjuvant isonicotinic acid hydrazide (INH) administration with misoprostol raises the rate of complete abortion
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| INH | Experimental | 3 tablets of isonicotinic acid hydrazide 300 mg will be given as single daily doses, 5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum three doses. |
|
| Misoprostol | Active Comparator | Misoprostol Alone 800 mcg every three hours up to maximum three doses |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Isonicotinic Acid Hydrazide | Drug | total dose 900 mg per day for 3 days then Misoprosrol 800mcg will be given to all patients for induction of abortion |
|
| Measure | Description | Time Frame |
|---|---|---|
| number of patients with complete abortion | number of patients with complete abortion | 12 hours |
| time from induction to abortion | time from induction to abortion | 12 hours |
| Measure | Description | Time Frame |
|---|---|---|
| number of the women will undergo dilatation and curettage after failed medical induction of abortion | number of the women will undergo dilatation and curettage after failed medical induction of abortion | 12 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
pregnant women with gestational age of less than 10 week
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| hany f Sallam, md | Contact | +20102435461 | 002 | hany.farouk@aswu.edu.eg |
| nahla waer Shady | Contact | +201022336052 | 002 | hanygyne@yahoo.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aswan University Hospital | Aswān | 81528 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007538 | Isoniazid |
| D016595 | Misoprostol |
| ID | Term |
|---|---|
| D006834 | Hydrazines |
| D009930 | Organic Chemicals |
| D007539 | Isonicotinic Acids |
| D000147 | Acids, Heterocyclic |
Not provided
Not provided
double blind randomized parallel assign controlled trial
Not provided
Not provided
double blind randomized parallel assign controlled trial
| Misoprostol | Drug | Misoprosrol 800mcg will be given to all patients for induction of abortion |
|
| D006571 |
| Heterocyclic Compounds |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D011459 | Prostaglandins E, Synthetic |
| D011465 | Prostaglandins, Synthetic |
| D011453 | Prostaglandins |
| D015777 | Eicosanoids |
| D005231 | Fatty Acids, Unsaturated |
| D005227 | Fatty Acids |
| D008055 | Lipids |
| D012898 | Autacoids |
| D018836 | Inflammation Mediators |
| D001685 | Biological Factors |